United States and India Reaffirm Counter-Narcotics Cooperation, Focusing on Intelligence Sharing and Precursor Controls
WASHINGTON — The White House Office of National Drug Control Policy (ONDCP) said in a statement on November 10 that the United States and India held the second India-U.S. Drug Policy Executive Working Group Meeting in New Delhi, where the two sides reaffirmed their commitment to strengthen bilateral counter-narcotics cooperation, with priorities including intelligence sharing, coordinated law enforcement action, precursor control, pharmaceutical supply chain integrity and drug demand reduction. The meeting, held on November 2-3, was hosted by India's Narcotics Control Bureau (NCB), part of the Ministry of Home Affairs.
The U.S. delegation was headed by Debbie Seguin, Acting Deputy Director of ONDCP, and the Indian delegation was led by Anurag Garg, Director General of the NCB. Pursuant to the terms of reference of the U.S.-India Drug Policy Framework, the meeting reviewed bilateral cooperation in combating illicit drug trafficking and identified the priority areas above, the White House statement said.
In his opening remarks, Anurag Garg highlighted India's Vision Roadmap 2026-2029. The statement said the roadmap outlines a comprehensive strategy emphasizing network-centric investigations, precursor control, financial investigations, prevention and rehabilitation, aimed at dismantling drug trafficking networks by targeting their entire ecosystem, including financiers, suppliers, facilitators and logistical networks.
ONDCP Director Sara Carter said the Executive Working Group and bilateral cooperation between the United States and India are vital to disrupting transnational drug trafficking networks and preventing the diversion of synthetic drugs and chemical precursors into global markets. She said that under President Trump's 2026 National Drug Control Strategy, the criminal networks and foreign terrorist organizations faced today operate like sophisticated, multinational logistics enterprises, and that the strategy must be equally targeted, partnering across borders to secure the commercial supply chains they exploit.
U.S. Ambassador to India Sergio Gor said President Trump has been clear that protecting the American people starts with securing the borders and cutting off illicit drug networks at the source. He said India and the United States are delivering real operational results, including choking off illicit precursor chemicals, securing commercial supply chains and dismantling the cartels that exploit them.
The statement said the two sides built on the progress of the first Executive Working Group meeting, held in Washington, D.C., in January 2026, discussed current drug trafficking trends and emerging threats, and welcomed joint and national initiatives at the operational and regulatory levels, including Operation MedMax, Operation WIPE and India's Voluntary Code of Conduct to prevent the diversion of precursor chemicals used to make synthetic drugs. Both sides agreed to further sharing of best practices in targeted law enforcement topics.
The White House statement said ONDCP leads and coordinates U.S. drug policy, develops and implements the President's National Drug Control Strategy, and supports communities through its programs.
(Source: The White House)
Source: The White House
Published by GSM · USA (original Chinese edition)
Photo: 图：白宫大楼（GSM 固定图库）。 / Photo: The White House (GSM asset library).
